Project Grant R21AG083488
Award Date
9/1/24
Completion Date
6/30/26
Dollars Obligated
$235K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Spokane, WA 99202, USA
Similar Awards
The Project Grant award with ID R01AG090337 is funded by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The total funding amount is $639,740.00 with a performance period from December 15, 2024 to November 30, 2029. The grant aims to explore the role of the CD38 enzyme and CD8 tissue resident memory (TRM) cells in the development of chronic lung fibrosis following viral pneumonia, including COVID-19. The research seeks to understand the...
The National Institute on Aging (NIA), under the federal Aging Research grant program (CFDA 93.866), awarded a $1,703,626 Project Grant to the University of North Dakota (UND) Division of Research & Economic Development. The grant, effective September 1, 2023 through August 31, 2026, will fund research to investigate the potential link between lung dysfunction and the progression of Alzheimer's disease (AD). Key objectives include: Characterizing the temporal changes in AD-related lung...
This $789,664 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support a comprehensive study to characterize the effect of age on the cellular microenvironment of the human lung and peripheral blood. The Icahn School of Medicine at Mount Sinai will leverage single-cell RNA sequencing and spatial transcriptomics to model age-related changes in cell composition, gene expression, and cellular interactions. The goal is to uncover new therapeutic...
The National Institute on Aging (NIA) awarded a $439,535 Project Grant under the Aging Research federal grant program (CFDA 93.866) to the University of Colorado from September 30, 2023 to September 29, 2025. This grant will fund research to investigate the interplay between active smooth muscle cell contractility and passive extracellular matrix mechanics in the aging bladder, with the goal of gaining insight into the development of lower urinary tract symptoms in older adults. The University...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a comprehensive evaluation of aging-related clinical decline trajectories in early-stage non-small cell lung cancer survivors aged 65 and older. The $115,411 award, with a performance period from August 2024 to May 2029, will leverage electronic health record data to measure dynamic changes in an electronic deficit accumulation index (EDAI) over time, and identify multilevel social...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research to investigate the role of fibroblast growth factor receptor (FGFR) signaling in the pathogenesis of idiopathic pulmonary fibrosis (IPF). The $461,146 award to Yale University will fund comprehensive in vitro studies examining the distinct functions of the mesenchymal C-isoform and epithelial B-isoform of FGFR, as well as establish the effects of modulating FGFR isoform-specific...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $3,161,352 in funding to the University of Colorado-Denver to investigate the effects of aerobic exercise training on peripheral endothelial function and cerebrovascular function in adults of different ages and sexes. The 5-year research project will conduct a randomized controlled trial to assess changes in vascular function outcomes and analyze associated molecular biomarkers,...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $485,375 to the University of Washington to investigate genomic alterations in skeletal muscle associated with aging. The overall goal is to better understand the molecular mechanisms underlying age-related decline in muscle function, with the potential to help prevent or slow down this process. Specifically, the project will: 1) Explore if alternative splicing of mRNA results in...
This federal Cooperative Agreement award, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), will support a research project focused on understanding the mechanisms behind the poor clinical outcomes observed in older patients with severe respiratory viral infections, such as COVID-19. The $528,011 award, effective July 1, 2024 through April 30, 2029, will enable New York University School of Medicine to conduct a comprehensive investigation of host immune responses and...
This federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) in the amount of $448,270 supports research on the role of alveolar type II (ATII) cell senescence in the pathogenesis of influenza in aging populations. The Ohio State University will conduct this 2-year research project aimed at defining the effects of aging, influenza virus infection, and a potential therapeutic treatment (CDP-choline) on ATII cell function, energy metabolism, and...